Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
statnews.com/pharmalot/2026/10/19/roche-investments-in-germany-gilead-bowel-disease-drug/
Pharmalittle: We’re reading about Roche investments in Germany ...
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
trib.al/0RlhVGl
Big pharma stocks near all-time highs as tech selloff pushes investors ...
Nana Morrison's Soul Food expands with new Huntersville location. What to know: Nana Morrison's, Charlotte's reader-voted best soul food restaurant ...
charlotteobserver.com/charlottefive/c5-food-drink/article317471502.html
Nana Morrison's Soul Food expands with new Huntersville location ...
HIV prevention drug hailed as breakthrough, but who gets access?: Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be ...
aljazeera.com/news/2026/10/1/hiv-prevention-drug-hailed-as-breakthrough-but-who-gets-access
HIV prevention drug hailed as breakthrough, but who gets access?
Kyverna’s cell therapy shows lasting autoimmune benefit: Today's biotech news includes FDA adcomm backing Grail's cancer blood test ...
statnews.com/2026/09/24/biotech-news-kyverna-cell-therapy-shows-lasting-autoimmune-benefit/
Kyverna’s cell therapy shows lasting autoimmune benefit
Why Gilead can’t stop talking about its ambitions in immunology: In this week's edition of "Adam's Biotech Scorecard," Adam also looks ahead ...
statnews.com/2026/09/24/gilead-immunology-inflammation-biotech-moderna-merck/
Why Gilead can’t stop talking about its ambitions in immunology
OpinionMedical breakthroughs rely on the government protecting intellectual property | Opinion
kansascity.com/opinion/article317171494.html
Medical breakthroughs rely on the government protecting intellectual ...
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
statnews.com/pharmalot/2026/09/10/novartis-investor-seeking-shake-up-gilead-uk-hiv-setback/
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up ...
The Testaments Season 2 Cast Changes Big Time With Charlie Carrick’s Role: The Testaments Season 2 is expanding its cast, with one actor promoted to series ...
comingsoon.net/tv/news/2186343-the-testaments-season-2-cast-charlie-carrick-haley-wong
The Testaments Season 2 Cast Changes Big Time With Charlie Carrick’s Role
FDA approved Gilead's new once-daily HIV pill for patients on complex regimens: Bixlenvo combines two existing Gilead drugs into a single tablet for adults whose ...
qz.com/gilead-bixlenvo-fda-approval-hiv-pill-082826
FDA approved Gilead's new once-daily HIV pill for patients on complex ...
Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
statnews.com/pharmalot/2026/08/28/astrazeneca-trial-failure-monstrous-conflict-of-interest/
Pharmalittle: We’re reading about an AstraZeneca trial failure ...
Publicis wins Gilead Sciences US media account: Gilead Sciences appoints Publicis to handle its U.S. media account.
adage.com/agencies/aa-publicis-wins-gilead-sciences-account/
Publicis wins Gilead Sciences US media account
Appeals court backs Gilead in ruling that threatens overseas prescription drug programs
qz.com/gilead-appeals-court-injunction-overseas-drug-imports-afps-081426
Appeals court backs Gilead in ruling that threatens overseas prescription ...
Three South African firms vie to make HIV prevention shot: Lenacapavir patent holder Gilead faces criticism at 26th International Aids Conference over limited ...
timeslive.co.za/news/sci-tech/2026-07-30-three-south-african-firms-vie-to-make-hiv-prevention-shot/
Three South African firms vie to make HIV prevention shot
Three biotechs with three news updates: Today's biotech news includes Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access ...
statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/
Three biotechs with three news updates
Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
statnews.com/pharmalot/2026/08/04/lilly-expands-retatrutide-access-program-gilead-court-victory/
Pharmalittle: We’re reading about a Lilly access program, a Gilead court ...
California Supreme Court sides with Gilead in ‘duty’ to innovate case: Advocates argued Gilead was negligent for slow-walking development of an HIV medicine that ...
statnews.com/pharmalot/2026/08/03/california-supreme-court-sides-with-gilead-in-duty-to-innovate-case/
California Supreme Court sides with Gilead in ‘duty’ to innovate case
South Africa edges closer to producing lenacapavir: The Department of Health announced that three local pharmaceutical firms are in the running to produce ...
ewn.co.za/2026/07/31/south-africa-edges-closer-to-producing-lenacapavir
South Africa edges closer to producing lenacapavir
How Gilead Is Working With Cultural Influencers to Bring Attention to HIV Stigma and Elevate HIV Prevention
hollywoodreporter.com/news/general-news/gilead-fights-to-end-hiv-stigma-1236643716/
How Gilead Is Working With Cultural Influencers to Bring Attention to HIV ...
Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
statnews.com/pharmalot/2026/07/22/trump-plans-tariffs-on-generics-merck-gilead-hiv-pill/
Pharmalittle: We’re reading about Trump’s plan for tariffs on generics ...
Clinical trial set to test two drugs for fast-growing Ebola outbreak: World Health Organization to launch clinical trials next week of two Ebola treatments ...
statnews.com/2026/06/24/ebola-treatment-trials-gilead-remdesivir-mappbio-mbp-134/
Clinical trial set to test two drugs for fast-growing Ebola outbreak
Key FactsWHO Declares International Emergency Over Ebola Spread
May 19, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: globalnews.ca
  • The WHO declared the Ebola outbreak caused by the rare Bundibugyo virus a public health emergency of international concern.

  • Delayed detection occurred as initial tests targeted a more common Ebola strain, allowing the virus to spread undetected for weeks.

  • No approved treatments or vaccines exist for this virus, so efforts focus on contact tracing, isolation, and community education.

  • WHO and local authorities have mobilized emergency supplies and response teams despite challenges posed by infrastructure and security issues.
  • This is the first time that a director-general has declared a PHEIC (public health emergency of international concern) before convening an emergency committee. I did not do this lightly.
    — Tedros Adhanom Ghebreyesus, WHO director-general, on declaring a global health emergency before convening the emergency committee during the Ebola outbreak in the DRC and Uganda.
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents: A group of AIDS activists obtained an R&D pact at the heart of a settlement ...
statnews.com/pharmalot/2026/07/13/aids-activists-slam-biden-deal-with-gilead-over-hiv-prevention-patents/
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug ...
Vulture Fest at Tribeca Fest Crossword: The Gilead Puzzle: Can you solve this crossword puzzle clue from Vulture’s Tribeca Festival zine? 3-Down ...
vulture.com/article/free-crossword-puzzle-tribeca-the-testaments.html
Vulture Fest at Tribeca Fest Crossword: The Gilead Puzzle
Gilead and Merck’s latest trial success and flop: Today's biotech news includes AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition ...
statnews.com/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/
Gilead and Merck’s latest trial success and flop
New content available: strengthen your approach to MASH screening, fibrosis staging, and treatment selection with practical guidance on NIT utilization and ... Show more

MASH in the Modern Era
Gilead: Expectations exceeded - | why the stock still falls: Gilead Sciences exceeds Q1 revenue | and profit expectations, yet the stock falls.
deraktionaer.de/artikel/pharma-biotech/gilead-erwartungen-uebertroffen-darum-faellt-die-aktie-trotzdem-20400637.html
Gilead: Expectations exceeded - | why the stock still falls
Key FactsGilead shares fall despite beating quarterly expectations
May 8, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
  • In the first quarter, Gilead’s revenue rose four percent to $7.0 billion, exceeding the expected $6.9 billion.

  • Earnings per share reached $2.03 instead of the expected $1.90.

  • Gilead raised its product-revenue forecast to $30.0–30.4 billion, but expects an adjusted loss per share of $3.25–2.85.

  • The company attributes the expected loss to special effects from numerous acquisitions, including announced deals with Arcellx, Tubulis, and Ouro Medicines.
The Testaments Director Jet Wilkinson Explains Episode 6's Deleted Scene: Director Jet Wilkinson talks about the deleted scene that pitted women against women in ...
cbr.com/the-testaments-director-jet-wilkinson-episode-6-deleted-scene/
The Testaments Director Jet Wilkinson Explains Episode 6's Deleted Scene
California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate'
reuters.com/legal/government/californias-highest-court-consider-whether-drugmakers-have-duty-innovate-2026-05-06/
California's highest court leans toward Gilead in considering ...
The Testaments Season 1 Episode 7 Includes Another Cameo as Suitors Are Named: After spending an hour looking back on Aunt Lydia's journey, The Testaments Season ...
tvfanatic.com/the-testaments-season-1-episode-7-review-commitment/
The Testaments Season 1 Episode 7 Includes Another Cameo as Suitors Are ...
Bay Area biotech giant Gilead to lay off 108 workers: Gilead Sciences plans to lay off 108 workers in Redwood City, marking the latest Bay Area biotech job cuts.
sfchronicle.com/tech/article/gilead-redwood-city-layoffs-22243158.php
Bay Area biotech giant Gilead to lay off 108 workers
AIDS group sues Trump administration over undisclosed agreement with Gilead: The group sued the administration for failing to disclose an R&D agreement that was ...
statnews.com/pharmalot/2026/04/28/aids-activist-group-sues-trump-administration-gilead-agreement/
AIDS group sues Trump administration over undisclosed agreement with ...
'It makes you feel more welcome. I didn’t have that in previous jobs' : Businesses in East Cork which give employment to people with intellectual ...
irishexaminer.com/news/munster/arid-41832572.html
'It makes you feel more welcome. I didn’t have that in previous ...
The Testaments Season 1 Episode 5 Brings an Essence of Bridgerton to Gilead: It's time for a ball, bringing an esseance of Bridgerton to the world of Gilead ...
tvfanatic.com/the-testaments-season-1-episode-5-review-ball/
The Testaments Season 1 Episode 5 Brings an Essence of Bridgerton to ...
Our anti-HIV jab LEN is here — now for quality checks in Ireland: South Africa’s first consignment of the twice-a-year anti-HIV injection lenacapavir arrived ...
dailymaverick.co.za/article/2026-04-12-our-anti-hiv-jab-len-is-here-now-for-quality-checks-in-ireland/
Our anti-HIV jab LEN is here — now for quality checks in Ireland
The Cast of The Testaments Is Expanding the World of The Handmaid’s Tale: The sequel to "The Handmaid’s Tale" has officially arrived. Starring Chase Infinit and ...
elle.com/culture/movies-tv/a71020612/the-testaments-season-1-cast-characters-explained/
The Cast of The Testaments Is Expanding the World of The Handmaid’s Tale
Finally, our LEN is here. Now for quality checks in Ireland: South Africa’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 ...
timeslive.co.za/news/south-africa/2026-04-07-finally-our-len-is-here-now-for-quality-checks-in-ireland/
Finally, our LEN is here. Now for quality checks in Ireland
⁉️ Who decided it was a good idea to send Daisy into Gilead to infiltrate it on #TheTestaments ? Ի՞նչ պետք է իմանալ եկամուտների տարեկան հայտարարագրման մասին. ՊԵԿ-ը տեսանյութ է հրապարակել Whoever it was must want Mayday to fail because she's proving ... Show more
Terns’ drug may not be as competitive as many initially thought: Today's biotech news covers a controversial class of drugs for Duchenne ...
statnews.com/2026/04/08/biotech-news-terns-drug-may-not-be-as-competitive-as-initially-believed/
Terns’ drug may not be as competitive as many initially thought
Gilead to buy cancer biotech Tubulis for more than $3 billion: Tubulis, based in Munich, is developing antibody-drug conjugates, which are next-generation ...
statnews.com/2026/04/07/gilead-sciences-acquisition-tubulis-adcs-chemotherapy-cancer/
Gilead to buy cancer biotech Tubulis for more than $3 billion
Pharmalittle: We’re reading about FDA backing domestic production, another Gilead deal, and more
statnews.com/pharmalot/2026/04/07/fda-backs-domestic-production-gilead-deal-merck-hiv-anthropic/
Pharmalittle: We’re reading about FDA backing domestic production ...
For up to $5 billion! Gilead acquires Munich-based biotech company: Gilead Sciences is acquiring the Munich-based biotech company Tubulis for up to $5 billion to ...
deraktionaer.de/artikel/pharma-biotech/fuer-bis-zu-5-milliarden-dollar-gilead-kauft-biotech-firma-aus-muenchen-20398537.html
For up to $5 billion! Gilead acquires Munich-based biotech company
Africa: Open Letter to Gilead - Prevention Should Not Be a Privilege: MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far ...
allafrica.com/stories/202604020203.html
Africa: Open Letter to Gilead - Prevention Should Not Be a Privilege
Bringing it home: SA is leading the charge to make anti-HIV jab for Africa : South Africa’s National Aids Council, Sanac, has asked local drug companies to ...
mg.co.za/health/2026-03-09-bringing-it-home-sa-is-leading-the-charge-to-make-anti-hiv-jab-for-africa/
Bringing it home: SA is leading the charge to make anti-HIV jab for ...
Psychedelic biotechs face scrutiny over YouTube promos: Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders ...
statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Psychedelic biotechs face scrutiny over YouTube promos